Literature DB >> 22855353

Pericardial syndromes: an update after the ESC guidelines 2004.

Petar M Seferović1, Arsen D Ristić, Ružica Maksimović, Dejan S Simeunović, Ivan Milinković, Jelena P Seferović Mitrović, Vladimir Kanjuh, Sabine Pankuweit, Bernhard Maisch.   

Abstract

Despite a myriad of causes, pericardial diseases present in few clinical syndromes. Acute pericarditis should be differentiated from aortic dissection, myocardial infarction, pneumonia/pleuritis, pulmonary embolism, pneumothorax, costochondritis, gastroesophageal reflux/neoplasm, and herpes zoster. High-risk features indicating hospitalization are: fever >38 °C, subacute onset, large effusion/tamponade, failure of non-steroidal anti-inflammatory drugs (NSAIDs), previous immunosuppression, trauma, anticoagulation, neoplasm, and myopericarditis. Treatment comprises 10-14-days NSAID plus 3 months colchicine (2 × 0.5 mg; 1 × 0.5 mg in patients <70 kg). Corticosteroids are avoided, except for autoimmunity, as they facilitate the recurrences. Echo-guided pericardiocentesis (±fluoroscopy) is indicated for tamponade and effusions >2 cm. Smaller effusions are drained if neoplastic, purulent or tuberculous etiology is suspected. In recurrent pericarditis, repeated testing for autoimmune and thyroid disease is appropriate. Pericardioscopy and pericardial/epicardial biopsy may clarify the etiology. Familial clustering was recently associated with tumor necrosis factor receptor-associated periodic syndrome (TNFRSF1A gene mutation). Treatment includes 10-14 days NSAIDs with colchicine 0.5 mg bid for up to 6 months. In non-responders, low-dose steroids, intrapericardial steroids, azathioprine, and cyclophosphamide can be tried. Successful management with interleukin-1 receptor antagonist (anakinra) was recently reported. Pericardiectomy remains the last option in >2 years severely symptomatic patients. In constriction, expansion of the heart is impaired by the rigid, chronically inflamed/thickened pericardium (no thickening ~20 %). Chest radiography, echocardiography, computerized tomography, magnetic resonance imaging, hemodynamics, and endomyocardial biopsy indicate the diagnosis. Pericardiectomy is the only treatment for permanent constriction. Predictors of poor survival are prior radiation, renal dysfunction, high pulmonary artery pressures, poor left ventricular function, hyponatremia, age, and simultaneous HIV and tuberculous infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22855353     DOI: 10.1007/s10741-012-9335-x

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  74 in total

1.  Color M-mode Doppler flow propagation velocity in cardiac tamponade.

Authors:  M Togni; R Shabetai; D Blanchard
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

Review 2.  Acute cardiac tamponade.

Authors:  David H Spodick
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

3.  Searching for pulsus paradoxus and correlates in cardiac tamponade.

Authors:  Eftychios Siniorakis; Spyridon Arvanitakis; Georgia Hardavella; Nikos Flessas; Antonis Samaras; Nikos Exadactylos
Journal:  Int J Cardiol       Date:  2009-07-19       Impact factor: 4.164

4.  The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy.

Authors:  Ferdinand S Leya; Dinesh Arab; Dominique Joyal; Krystyna M Shioura; Bruce E Lewis; Lowell H Steen; Leslie Cho
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

5.  Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study.

Authors:  Dali Feng; James Glockner; Kyehun Kim; Matthew Martinez; Imran S Syed; Philip Araoz; Jerome Breen; Raul E Espinosa; Thoralf Sundt; Hartzell V Schaff; Jae K Oh
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

6.  The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis.

Authors:  B Komsuoğlu; O Göldelï; K Kulan; S S Komsuoğlu
Journal:  Eur Heart J       Date:  1995-08       Impact factor: 29.983

7.  Predictors of constrictive pericarditis after tuberculous pericarditis.

Authors:  P K Suwan; S Potjalongsilp
Journal:  Br Heart J       Date:  1995-02

Review 8.  Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management.

Authors:  Markus Schwefer; Rene Aschenbach; Jan Heidemann; Celia Mey; Harald Lapp
Journal:  Eur J Cardiothorac Surg       Date:  2009-04-25       Impact factor: 4.191

Review 9.  Myopericarditis: Etiology, management, and prognosis.

Authors:  Massimo Imazio; Rita Trinchero
Journal:  Int J Cardiol       Date:  2008-01-24       Impact factor: 4.164

10.  Indicators of poor prognosis of acute pericarditis.

Authors:  Massimo Imazio; Enrico Cecchi; Brunella Demichelis; Salvatore Ierna; Daniela Demarie; Aldo Ghisio; Franco Pomari; Luisella Coda; Riccardo Belli; Rita Trinchero
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

View more
  13 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 2.  Tumor necrosis factor-associated periodic syndrome in adults.

Authors:  Sharika Gopakumar Menon; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-09-23       Impact factor: 2.631

Review 3.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 4.  Multimodality imaging of pericardial disease.

Authors:  Paul C Cremer; Deborah H Kwon
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

5.  Postcardiotomy syndrome: recurrent cardiac tamponade and an exquisite steroid response.

Authors:  Douglas Fink; Alessandra Frigiola; Shay Cullen
Journal:  BMJ Case Rep       Date:  2012-12-19

Review 6.  Recurrent pericarditis: new and emerging therapeutic options.

Authors:  Massimo Imazio; George Lazaros; Antonio Brucato; Fiorenzo Gaita
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

Review 7.  Targeting interleukin-1 in heart disease.

Authors:  Benjamin W Van Tassell; Stefano Toldo; Eleonora Mezzaroma; Antonio Abbate
Journal:  Circulation       Date:  2013-10-22       Impact factor: 29.690

Review 8.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 9.  Management of Malignant Pericardial Effusion.

Authors:  Mary Petrofsky
Journal:  J Adv Pract Oncol       Date:  2014 Jul-Aug

10.  Purulent pericarditis after liver abscess: a case report.

Authors:  María Fidalgo García; Juan Carlos Rodríguez Sanjuán; María Riaño Molleda; Marta González Andaluz; Hector Real Noval; Manuel Gómez Fleitas
Journal:  Case Rep Med       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.